Citation: Fm. Sakr et al., ENHANCED SYSTEMIC BIOAVAILABILITY OF INTRAVENOUS AND RECTAL PIROXICAMIN RABBITS FOLLOWING ORAL-ADMINISTRATION OF CHENODEOXYCHOLIC ACID, STP pharma sciences, 6(3), 1996, pp. 211-215
Citation: Fm. Sakr, NASAL ADMINISTRATION OF GLUCAGON COMBINED WITH DIMETHYL-BETA-CYCLODEXTRIN - COMPARISON OF PHARMACOKINETICS AND PHARMACODYNAMICS OF SPRAY AND POWDER FORMULATIONS, International journal of pharmaceutics, 132(1-2), 1996, pp. 189-194
Citation: Fm. Sakr, THE PHARMACOKINETICS OF PULMONARY NEBULIZED INSULIN AND ITS EFFECT ONGLUCOSE-TOLERANCE IN STREPTOZOTOCIN-INDUCED DIABETIC RABBITS, International journal of pharmaceutics, 128(1-2), 1996, pp. 215-222
Citation: Fm. Sakr et al., DESIGN AND EVALUATION OF A DRY SOLIDIFICATION TECHNIQUE FOR PREPARINGPHARMACEUTICAL BEADS, STP pharma sciences, 5(4), 1995, pp. 291-295